Mr Bruce Pritchard
- Job title
- Chair of Court
- Qualifications
- BA, CA
An accountant by training, Bruce has spent over two decades working in the life sciences and pharmaceutical industry. He has more than fourteen years' experience with Liminal BioSciences and has held a number of senior global positions across the organisation.
Prior to being appointed CEO with Liminal, he became COO in 2014; previously, he was the Group CFO, a role he had held since 2008. Bruce brings a proven track record of success in strategic acquisitions and in raising debt and equity finance.
As well as being a chartered accountant, Bruce has many years of experience in general management and operations. Prior to joining Liminal, Bruce worked as a senior director for CV Therapeutics, an NASDAQ listed biopharmaceutical company.
Bruce is a graduate of Heriot-Watt University where he gained a BA in Accountancy and Computer Science. He is a member of the Institute of Chartered Accountants of Scotland and a Fellow of the Institute of Directors. He is also Chair of Board of Porton Biopharma Limited the Chair of Court at Heriot-Watt University. He was recently President of The Institute of Chartered Accountants of Scotland.
As well as Court, Bruce is a member of:
- Court Interim Business Committee (Chair)
- Finance Committee
- Global Student Life Committee
- Governance and Nominations Committee (Chair)
- Remuneration Committee
- Staff Committee